OS1.F Otsuka Holdings Co. Ltd

Healthcare Pharmaceuticals Frankfurt Exchange
69.00 EUR
Close of Nov 13, 2026
44.80 71.00
Market cap
EUR 36.1B
P/E
17.2x
P/B
1.98x
ROE
13.4%
Dividend yield
1.65%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is OS1.F undervalued?

Graham number
Price69.00
Graham value56.11
Premium23.0%

OS1.F trades 23.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Otsuka Holdings Co. Ltd fundamental analysis

No fundamental analysis for Otsuka Holdings Co. Ltd yet.

Otsuka Holdings Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Otsuka Holdings Co. Ltd

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products…

Full company profile